Abbott (ABT), Reata Enter 2G AIM Development Collaboration; Abbot to Pay $400M License Fee
Go back to Abbott (ABT), Reata Enter 2G AIM Development Collaboration; Abbot to Pay $400M License Fee| Abbott Laboratories (NYSE: ABT) | Delayed: 114.14 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $114.14 | 52 Week High | $46.38 | |||
| Open | $114.14 | 52 Week Low | $36.00 | |||
| Day High | $114.14 | P/E | 76.09 | |||
| Day Low | $114.14 | EPS | $1.50 | |||
| Volume | 409 | |||||
